These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 15979029)

  • 1. Short-term, high dose enzyme replacement therapy in sialidosis mice.
    Wang D; Bonten EJ; Yogalingam G; Mann L; d'Azzo A
    Mol Genet Metab; 2005 Jul; 85(3):181-9. PubMed ID: 15979029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis.
    Bonten EJ; Wang D; Toy JN; Mann L; Mignardot A; Yogalingam G; D'Azzo A
    FASEB J; 2004 Jun; 18(9):971-3. PubMed ID: 15084520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement.
    Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K
    Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency].
    Guo YK; Xie DH; Yang XM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):79-84. PubMed ID: 16562682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
    Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1.
    Seyrantepe V; Hinek A; Peng J; Fedjaev M; Ernest S; Kadota Y; Canuel M; Itoh K; Morales CR; Lavoie J; Tremblay J; Pshezhetsky AV
    Circulation; 2008 Apr; 117(15):1973-81. PubMed ID: 18391110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.
    Bonten EJ; Yogalingam G; Hu H; Gomero E; van de Vlekkert D; d'Azzo A
    Biochim Biophys Acta; 2013 Oct; 1832(10):1784-92. PubMed ID: 23770387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression.
    Pattison S; Pankarican M; Rupar CA; Graham FL; Igdoura SA
    Hum Mutat; 2004 Jan; 23(1):32-9. PubMed ID: 14695530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exclusion of NEU1 and PPGB from candidate genes for a lysosomal storage disease in Japanese Black cattle.
    Masoudi AA; Yamato O; Yoneda K; Tsuji T; Mikami O; Kunieda T
    Anim Sci J; 2009 Oct; 80(5):611-5. PubMed ID: 20163628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathology of NEU1 gene in sialidosis.
    Seyrantepe V; Poupetova H; Froissart R; Zabot MT; Maire I; Pshezhetsky AV
    Hum Mutat; 2003 Nov; 22(5):343-52. PubMed ID: 14517945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase.
    Loren DJ; Campos Y; d'Azzo A; Wyble L; Grange DK; Gilbert-Barness E; White FV; Hamvas A
    J Perinatol; 2005 Jul; 25(7):491-4. PubMed ID: 15908988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice.
    de Geest N; Bonten E; Mann L; de Sousa-Hitzler J; Hahn C; d'Azzo A
    Hum Mol Genet; 2002 Jun; 11(12):1455-64. PubMed ID: 12023988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
    Kwak JE; Son MY; Son YS; Son MJ; Cho YS
    Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-mediated gene therapy for sialidosis.
    van de Vlekkert D; Hu H; Weesner JA; Fremuth LE; Brown SA; Lu M; Gomero E; Campos Y; Sheppard H; d'Azzo A
    Mol Ther; 2024 Jul; 32(7):2094-2112. PubMed ID: 38796704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy corrects the neurological deficits of mice with sialidosis.
    Hwu WL; Chang K; Liu YH; Wang HC; Lee NC; Chien YH
    Gene Ther; 2024 May; 31(5-6):263-272. PubMed ID: 38321198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective protein/cathepsin A rescues N-glycosylation defects in neuraminidase-1.
    Wang D; Zaitsev S; Taylor G; d'Azzo A; Bonten E
    Biochim Biophys Acta; 2009 Apr; 1790(4):275-82. PubMed ID: 19714866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement improves nervous system pathology and function in a mouse model for metachromatic leukodystrophy.
    Matzner U; Herbst E; Hedayati KK; Lüllmann-Rauch R; Wessig C; Schröder S; Eistrup C; Möller C; Fogh J; Gieselmann V
    Hum Mol Genet; 2005 May; 14(9):1139-52. PubMed ID: 15772092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term enzyme replacement in the murine model of Sanfilippo syndrome type B.
    Yu WH; Zhao KW; Ryazantsev S; Rozengurt N; Neufeld EF
    Mol Genet Metab; 2000 Dec; 71(4):573-80. PubMed ID: 11136549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of human lysosomal neuraminidase to mature lysosomes requires protective protein/cathepsin A.
    van der Spoel A; Bonten E; d'Azzo A
    EMBO J; 1998 Mar; 17(6):1588-97. PubMed ID: 9501080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of endogenous sialidases of human monocytes during cellular differentiation into macrophages.
    Stamatos NM; Liang F; Nan X; Landry K; Cross AS; Wang LX; Pshezhetsky AV
    FEBS J; 2005 May; 272(10):2545-56. PubMed ID: 15885103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.